FHIT and gastric adenocarcinoma: To determine if FHIT alterations are frequent in gastric carcinomas, Lee SH et al (2001) examined FHIT LOH, aberrant RT–PCR products and Fhit protein expression in 35 gastric adenocarcinomas.